Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-005862
Filing Date
2025-02-14
Accepted
2025-02-14 18:22:49
Documents
1
Period of Report
2025-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1739575362.html 4  
1 FORM 4 wk-form4_1739575362.xml 4 3498
  Complete submission text file 0001628280-25-005862.txt   4978
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Issuer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ADC THERAPEUTICS SA BIOPOLE ROUTE DE LA COMICHE 3B EPALINGES V8 1066
Business Address
Zaki Mohamed (Reporting) CIK: 0002000697 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39071 | Film No.: 25631655